QHSLab Expands Digital Prescription Product Portfolio in 2022
16 févr. 2022 08h00 HE
|
USA Equities Corp
The company is introducing additional point-of-care digital healthcare and clinical decision-making tools into the market throughout the coming year.A major milestone includes the launch of the...
USA Equities Corp's QHSLab Digital Health Platform Strategy is Backed by Latest Research Published in the Journal of the American Medical Association (JAMA)
07 janv. 2022 08h30 HE
|
USA Equities Corp
The JAMA research found that digital health interventions supporting patient self-management improves primary care for patients with multiple chronic conditions.QHSLab supports medical decision making...
USA Equities Corp. Introduces AllergiQT™ – Quick Test, Further Expanding Market Presence
29 nov. 2021 08h00 HE
|
USA Equities Corp
FDA-cleared and Easily Administered Skin Test for Environmental and Food Allergens; AllergiQT™ – Quick Test Targets Non-Allergy Specialists in Primary Care SettingsStrengthens USA Equities...
USA Equities Corp. Announces Third Quarter 2021 Financial Results And Conversion of Secured Convertible Promissory Note
16 nov. 2021 07h30 HE
|
USA Equities Corp
● Revenue Surpassed $1 million for Nine Months of 2021 Compared to $0 for the Same Period 2020 ● Gross Margin of 48% in Q3 Increased 290 Basis Points Versus Q2 2021 ● Issuance of 76,923 Shares...
USA Equities Corp. Launches Q-Scale Product to Meet Growing Mental Health End Market Demand
19 oct. 2021 08h30 HE
|
USA Equities Corp
Strengthening Business Model and Expanding Product Portfolio in Large Addressable End MarketQ-Scale Represents a Compelling and Reimbursable Value Proposition for USAQ’s Physician ClientsFurther...
USA Equities Corp. Issues Updated September 2021 Investor Presentation
22 sept. 2021 08h30 HE
|
USA Equities Corp
●Superior Business Model and Strategic Position Validated By Growing Client Base and Product Portfolio ●Addressable Market Opportunity Includes Over 250,000 Independent Primary Care...
USA Equities Corp. Announces Strong Second Quarter 2021 Results
17 août 2021 08h30 HE
|
USA Equities Corp
Second Quarter 2021 Financial Results In-Line with July Pre-AnnouncementSuccessful $750,000 Capital Raise Increases Financial Flexibility to Execute on Growth StrategyAcquired AllergiEnd® Assets...
Allergies in Primary Care: A Study of the Allergy Management Evaluation Tool Published on Consultant360 Specialty Network
05 août 2021 07h59 HE
|
USA Equities Corp
-USA Equities Corp. Business Model and Strategic Direction Favorably Aligned with Industry Growth Drivers-West Palm Beach, FL, Aug. 05, 2021 (GLOBE NEWSWIRE) -- USA Equities Corp. (OTCQB: USAQ), a...
USA Equities Corp. Announces Strong Second Quarter 2021 Financial Results
15 juil. 2021 07h30 HE
|
USA Equities Corp
● Revenue Grew 50% to $456,219 Compared to Q1 2021 ● Gross Margin of 46% Increased 164 Basis Points Versus Q1 2021 ● Strengthening of Company Financial Position and Strategic Relationships West Palm...
USA Equities Corp Announces the Signing of a Distribution Agreement with a Prominent Physician Management Services Firm For its AllergiEnd® Products and Services
29 juin 2021 07h30 HE
|
USA Equities Corp
-Continued Momentum Expanding Independent Care Practitioner Network- West Palm Beach, FL, June 29, 2021 (GLOBE NEWSWIRE) -- USA Equities Corp. (OTCQB: USAQ), a company focused on value-based...